According to IMARC Group’s latest report, titled “Virus Filtration Market: Industry Trends, Share, Growth, Opportunity and Forecast 2023-2028,” the global virus filtration market size reached US$ 3.9 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 6.9 Billion by 2028, exhibiting a growth rate (CAGR) of 9.5% during 2023-2028. Virus filtration refers to a robust and effective virus clearance technology used in the manufacturing of biological therapeutics and plasma-derived product drug substances. It consists of a polymeric membrane barrier to retain virus particles on the surface and within the pores of the membrane from biotech and plasma processes. It provides a critical defense mechanism against the introduction of adventitious viruses into a different class of medicines. Request Free Sample Report: https://www.imarcgroup.com/virus-filtration-market/requestsample Market Trends Biological therapeutic products are generally produced using mammalian cell lines or human plasma, which increases the risk of contamination. This, in confluence with the rising need for therapeutic products on account of the growing prevalence of chronic diseases, represents one of the key factors driving the demand for virus filtration solutions across the globe. Apart from this, governing agencies of numerous countries are implementing stringent regulations to ensure the virological safety of biological therapeutics. This is encouraging pharmaceutical manufacturers to integrate virus filtration methods to evaluate and mitigate the risks of virus contamination. Ask Analyst and Browse Full Report with TOC & List of Figure: https://www.imarcgroup.com/request?type=report&id=3423&flag=C List of Key Companies Covered in this Market Report:
- Asahi Kasei Medical Co. Ltd.
- Charles River Laboratories Inc.
- Clean Cells
- Danaher Corporation
- Merck KGaA
- Sartorius AG,
- Thermo Fisher Scientific Inc.
- Consumables
- Kits and Reagents
- Others
- Instruments
- Filtration Systems
- Chromatography Systems
- Services
- Biologicals
- Vaccines and Therapeutics
- Blood and Blood Products
- Cellular and Gene Therapy Products
- Others
- Medical Devices
- Water Purification
- Air Purification
- Others
- Biopharmaceuticals and Biotechnology Companies
- Contract Research Organizations
- Academic Institutes and Research Laboratories
- Others
- North America (U.S. & Canada)
- Europe (Germany, United Kingdom, France, Italy, Spain, Russia, and Others)
- Asia Pacific (China, India, Japan, South Korea, Indonesia, Australia, and Others)
- Latin America (Brazil, Mexico)
- Middle East & Africa
- Market Performance (2017-2022)
- Market Outlook (2023- 2028)
- Porter’s Five Forces Analysis
- Market Drivers and Success Factors
- SWOT Analysis
- Value Chain
- Comprehensive Mapping of the Competitive Landscape